Home »
1999 Issues »
64 FR (01/27/1999) » 99-1795. Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units From Prior Collections From Donors ...
99-1795. Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units From Prior Collections From Donors ...
[Federal Register Volume 64, Number 17 (Wednesday, January 27, 1999)]
[Notices]
[Page 4112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1795]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 98D-0143]
Agency Information Collection Activities; Announcement of OMB
Approval; Guidance for Industry: Current Good Manufacturing Practice
for Blood and Blood Components: (1) Quarantine and Disposition of Units
From Prior Collections From Donors with Repeatedly Reactive Screening
Test for Antibody to Hepatitis C Virus (Anti-HCV); (2) Supplemental
Testing, and the Notification of Consignees and Blood Recipients of
Donor Test Results for Anti-HCV
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Guidance for Industry: Current
Good Manufacturing Practice for Blood and Blood Components: (1)
Quarantine and Disposition of Units From Prior Collections From Donors
with Repeatedly Reactive Screening Test for Antibody to Hepatitis C
Virus (Anti-HCV); (2) Supplemental Testing, and the Notification of
Consignees and Blood Recipients of Donor Test Results for Anti-HCV''
has been approved by the Office of Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of
Information Resources Management (HFA-250), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In the Federal Register of October 21, 1998
(63 FR 56192), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0388.
The approval expires on April 30, 1999.
Dated: January 20, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-1795 Filed 1-26-99; 8:45 am]
BILLING CODE 4160-01-F
Document Information
- Published:
- 01/27/1999
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 99-1795
- Pages:
- 4112-4112 (1 pages)
- Docket Numbers:
- Docket No. 98D-0143
- PDF File:
-
99-1795.pdf